10 Stocks Moving In Monday's Pre-Market Session
Trevena Inc (NASDAQ: TRVN) shares rose 17.87 percent to $9.50 in pre-market trading after the company reported that it has received the U.S. Food and Drug Administration Breakthrough Therapy designation for oliceridine for the management of moderate-to-severe acute pain.
Radius Health Inc (NASDAQ: RDUS) shares rose 15.30 percent to $31.13 in the pre-market trading session after gaining 7.23 percent on Friday.
Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) shares rose 13.29 percent to $11.25 in the pre-market trading session after the company reported that the FDA has granted orphan drug designation for BPX-501.
Central European Media Enterprises Ltd. (NASDAQ: CETV) shares rose 11.45 percent to $2.53 in pre-market trading. Central European Media posted a Q4 loss from continuing operations of $0.02 per share on revenue of $195.6 million. The company also reported that it has entered into a new 469 million euros term loan, guaranteed by Time Warner.
Magic Software Enterprises Ltd. (NASDAQ: MGIC) shares rose 7.11 percent to $6.63 in pre-market trading after the company reported that its board has declared a cash dividend for the second half of 2015.
Groupon Inc (NASDAQ: GRPN) shares rose 4.89 percent to $4.29 in pre-market trading after gaining 6.51 percent on Friday.
Lumber Liquidators Holdings Inc (NYSE: LL) shares fell 17.66 percent to $11.70 in pre-market trading following a new CDC cancer-risk report.
Chimerix Inc (NASDAQ: CMRX) fell 16.64 percent to $6.36 in pre-market trading after the company reported that its Phase 3 SUPPRESS trial of brincidofovir did not meet primary endpoint for the prevention of cytomegalovirus infection following hematopoietic cell transplantation.
Newmont Mining Corp (NYSE: NEM) shares fell 4.19 percent to $23.80 in pre-market trading after declining 0.96 percent on Friday.
Randgold Resources Ltd. (ADR) (NASDAQ: GOLD) shares fell 2.37 percent to $88.70 in pre-market trading after rising 0.65 percent on Friday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.